The Prevalence of Retinopathy of Prematurity and Relationship with Gestational Age and Birth-Weight
Selim Cevher1*, Emine Alyamaç Sukgen2
1Hitit University, Çorum, Turkey
2Adana Numune Training and Research Hospital, Adana, Turkey
* Corresponding author: s.cewher@hotmail.com
Presented at the 4th International Symposium on Innovative Approaches in Health and Sports Sciences (ISAS WINTER-2019 (HSS)), Samsun, Turkey, Nov 22, 2019
SETSCI Conference Proceedings, 2019, 12, Page (s): 15-16 , https://doi.org/10.36287/setsci.4.9.016
Published Date: 23 December 2019
In this study, we aimed to determine the incidence of retinopathy of prematurity (ROP) and the risk factors especially gestational age (GA) and birth weight (BW) associated with its development. Three hundred eighty-two consecutive infants were included in the data analysis. BW and GA were evaluated according to the development of ROP. ROP was detected in 133 infants (35%) of 382 infants; of those 58% had stage 1 disease, 10% had stage 2 disease, 22% had stage 3, 2% had stage 4a, 1% had stage 4b, 1% had stage 5 and 8% had aggressive posterior retinopathy of prematurity disease. Low BW and low GA was statistically associated with ROP. In conclusion, the incidence of ROP was detected at 35%. ROP is known to be a multifactorial disease, the major risk factors are low GA and low BW.
Keywords - Retinopathy of Prematurity, Risk Factors, Birth Wight, Gestational Age, Incidence
[1] Hoogerwerf A., et al. “Incidence of retinopathy of prematurity over the last decade in the Central Netherlands”. Neonatology 98.2 (2010): 137-142.
[2] Y. Xu, et al. “Screening for retinopathy of prematurity in China: a neonatal units-based prospective study,” Investigative Ophthalmology&Visual Science, vol. 54,no. 13, pp. 8229–8236, 2013.
[3] Li, Q., et al. (2016). A prospective study of the incidence of retinopathy of prematurity in China: evaluation of different screening criteria. Journal of ophthalmology, 2016.
[4] Zin AA, et al. Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics. 2010;126:e410–e417.
[5] Alizadeh, Y., et al (2015). Incidence and risk factors for retinopathy of prematurity in North of Iran. Journal of ophthalmic & vision research, 10(4), 424.
[6] Bas, AY, et al. "Incidence and severity of retinopathy of prematurity in Turkey." British Journal of Ophthalmology 99.10 (2015): 1311-1314
[7] Joint Working Party of the Royal College of Ophthalmologists and the British Association of Perinatal Medicine. “Retinopathy of prematurity: guidelines for screening and treatment. The report of a Joint Working Party of the Royal College of Ophthalmologists and the British Association of Perinatal Medicine”. Early Human Development 46.3 (1996): 239-258.
[8] Wilkinson AR., et al. “UK retinopathy of prematurity guideline”. Early Human Development 84 (2008): 71-74.
[9] Xu Y., et al. “Screening for retinopathy of prematurity in China: a neonatal units-based prospective study”. Investigative Ophthalmology and Visual Science 54.13 (2013): 8229-8236.
[10] Bas AY., et al. “Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicenter study in 69 neonatal intensive care units”. British Journal of Ophthalmology 102.12 (2018): 1711-1716.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |